Dopaminergic mechanism of antidepressant action in depressed patients.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Affective Disorders

• Publication date

  2005-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.JAD.2004.12.010PMID 15820269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

  2005cited by this paper
• Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients

  2004cited by this paper
• Dopamine and Depression

  2002cited by this paper
• The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.

  2001cited by this paper
• Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.

  2000cited by this paper
• Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats.

  2000cited by this paper
• Antidepressant-like activity of amisulpride in two animal models of depression

  2000cited by this paper
• Antidepressant Action of Sulpiride. Results of a Placebo-Controlled Double-Blind Trial

  1999cited by this paper
• Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease

  1999cited by this paper
• Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT

  1999cited by this paper
• Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.

  1998cited by this paper
• SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment

  1998cited by this paper
• Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use

  1998cited by this paper
• Animal Models to Detect Antidepressants

  1997cited by this paper
• In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression.

  1997cited by this paper
• Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls.

  1997cited by this paper
• Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.

  1997cited by this paper
• Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

  1997cited by this paper
• The mesolimbic dopamine system as a target for rapid antidepressant action

  1997cited by this paper
• Antidepressants : new pharmacological strategies

  1997cited by this paper
• Clinical and psychometric correlates of dopamine D2 binding in depression

  1997cited by this paper
• Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography

  1996cited by this paper
• Dopamine and depression — Striatal dopamine D2 receptor SPECT before and after antidepressant therapy

  1996cited by this paper
• Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.

  1996cited by this paper
• Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine

  1994cited by this paper
• Dopamine D2 receptors in depression measured with single photon emission computed tomography.

  1994cited by this paper
• The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders

  1993cited by this paper
• Blockade of DA autoreceptors: possible mechanism of antidepressant action of L-Sulpiride

  1990cited by this paper
• Sensitization to the Actions of Antidepressant Drugs

  1989cited by this paper
• Psychoactive drugs: tolerance and sensitization

  1989cited by this paper
• Treating resistant depression

  1987cited by this paper
• Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.

  1985cited by this paper
• Assessing Anhedonia in Psychiatric Patients: The Pleasure Scale

  1983cited by this paper
• Assessing anhedonia in psychiatric patients.

  1983cited by this paper
• The use of analogue scales in rating subjective feelings

  1974cited by this paper

• Dopaminergic receptors involvement in the antidepressant-like effect of N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide in mice.

  2025cites this paper
• Osteopontin knockdown reverses HIV-induced cognitive deficits and Influences Motivation-Related behavior.

  2025cites this paper
• Using rodent data to elucidate dopaminergic mechanisms of ADHD: Implications for human personality

  2024cites this paper
• Fractal Analysis of Electrophysiological Signals to Detect and Monitor Depression: What We Know So Far?

  2024cites this paper
• The antidepressant-like effect and proposed mechanism of action of TPN672MA, a novel serotonin-dopamine receptor modulator for the treatment of schizophrenia.

  2024cites this paper
• Secondary analysis of neurotransmitter metabolism and cognitive function in first-diagnosed, drug-naïve adult patients with major depressive disorder.

  2024cites this paper
• [Possibilities of «therapeutic retargeting» of 3-hydroxypyridine and succinic acid derivatives due to their dopaminergic action].

  2024cites this paper
• Time perception reflects individual differences in motor and non-motor symptoms of Parkinson’s disease

  2023cites this paper
• Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

  2023cites this paper
• The monoaminergic pathways are involved in the antidepressant-like effect of quercetin

  2023cites this paper
• Optogenetic stimulation of transmission from prelimbic cortex to nucleus accumbens core overcomes resistance to venlafaxine in an animal model of treatment-resistant depression.

  2023cites this paper
• The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights

  2023cites this paper
• Computational reinforcement learning, reward (and punishment), and dopamine in psychiatric disorders

  2022cites this paper
• Blockade of dopamine D3 receptor in ventral tegmental area attenuating contextual fear memory.

  2022cites this paper
• Antidepressant-like effects of cinnamamide derivative M2 via D2 receptors in the mouse medial prefrontal cortex

  2022cites this paper
• Neural Circuits Underlying the Pathophysiology of Major Depression

  2022cites this paper
• Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice

  2022cites this paper
• Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies

  2022cites this paper
• Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence.

  2021cites this paper
• Godot is not coming: when we will let innovations enter psychiatry?

  2021influential citation
• Transcriptome-wide association study identifies new susceptibility genes and pathways for depression

  2021cites this paper
• Between Temperament and Psychopathology: Examples from Neuropharmacological Challenge Tests in Healthy Humans

  2021cites this paper
• INVOLVEMENT OF MONOAMINERGIC SYSTEM IN THE ANTIDEPRESSANT-LIKE EFFECT OF Ocimum sanctum (LINN.) LEAVES EXTRACT IN TAIL SUSPENSION TEST IN MICE

  2021cites this paper
• The role of ventral tegmental area orexinergic afferents in depressive-like behavior in a chronic unpredictable mild stress (CUMS) mouse model.

  2021cites this paper
• Involvement of D2 receptor in the NAc in chronic unpredictable stress-induced depression-like behaviors

  2020cites this paper
• Transfer entropy applied on EEG in depression reveals aberrated dynamics

  2020cites this paper
• Bacterial Metabolites of Human Gut Microbiota Correlating with Depression

  2020cites this paper
• Factor Structure and Measurement Invariance of the Chinese version of the Snaith-Hamilton Pleasure Scale (SHAPS) in Non-clinical and Clinical populations.

  2020cites this paper
• An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective

  2020cites this paper
• Role of Mesolimbic Brain-Derived Neurotrophic Factor in Depression.

  2019cites this paper
• Mechanisms and treatment of late-life depression

  2019cites this paper
• Regulation of defeat-induced social avoidance by medial amygdala DRD1 in male and female prairie voles

  2019cites this paper
• Threat-related disorders as persistent motivational states of defense.

  2019cites this paper
• Effects of Chaenomeles maulei Fruit Juice on Reserpine-induced Behavioral Changes in Rats.

  2019cites this paper
• Molecular aspects of depression: A review from neurobiology to treatment

  2019cites this paper
• Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients

  2019cites this paper
• Soy undecapeptide induces Drosophila hind leg grooming via dopamine receptor.

  2018cites this paper
• Depression and sadness

  2018cites this paper
• Mechanisms of reward in depression : an intervention study investigating the acute effects of lurasidone on cerebral blood flow and the neural correlates of reward and penalty processing

  2018cites this paper
• [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].

  2018cites this paper
• Butanol Fraction of Olax Subscorpioidea Produces Antidepressant Effect: Evidence for the Involvement of Monoaminergic Neurotransmission

  2018cites this paper
• L’anhédonie dans la dépression unipolaire : de son évaluation à sa prise en charge

  2018cites this paper
• Isolation and Characterization of Two New Secondary Metabolites From Quercus incana and Their Antidepressant- and Anxiolytic-Like Potential

  2018cites this paper
• Effectiveness of Reward-Based Task on Affective Levels of Depressed Individuals

  2018cites this paper
• Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy

  2017cites this paper
• Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness

  2017cites this paper
• Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`

  2017cites this paper
• Using positron emission tomography to investigate hormone-mediated neurochemical changes across the female lifespan: implications for depression

  2017cites this paper
• Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

  2017cites this paper
• Hydroethanolic extract of Carthamus tinctorius induces antidepressant-like effects: modulation by dopaminergic and serotonergic systems in tail suspension test in mice

  2017cites this paper
• Docosahexaenoic acid induces glial cell-line derived neurotrophic factor release in C6 glioma cells: Implications of antidepressant effects for docosahexaenoic acid.

  2017cites this paper
• Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression

  2017cites this paper
• Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence.

  2017cites this paper
• [P4–004]: THE COMBINATION OF CITALOPRAM AND RIVASTIGMINE IN THE TREATMENT OF MOOD DISORDER AND COGNITIVE IMPAIRMENT DUE TO CEREBROVASCULAR DISEASE: A CASE REPORT AND LITERATURE REVIEW

  2017cites this paper
• Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.

  2016cites this paper
• Catecholamine pathway polymorphisms and antidepressant response

  2016cites this paper
• A sphingolipid mechanism for behavioral extinction

  2016cites this paper
• Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway.

  2016cites this paper
• Objective and specific tracking of anhedonia via event-related potentials in individuals with cocaine use disorders.

  2016cites this paper
• Assessing anhedonia in depression: Potentials and pitfalls.

  2016cites this paper
• Fluoxetine moderates amphetamine response in chronically stressed rats with high and low levels of positive affectivity

  2016cites this paper
• Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters

  2016cites this paper
• The chronic mild stress (CMS) model of depression: History, evaluation and usage

  2016influential citation
• The role of purinergic and dopaminergic systems on MK-801-induced antidepressant effects in zebrafish.

  2015cites this paper
• In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.

  2015cites this paper
• Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β- (4-Iodophenyl)tropane SPECT Study

  2015cites this paper
• Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.

  2015cites this paper
• Common variants of HTR1A and SLC6A4 confer the increasing risk of Schizophrenia susceptibility: A population‐based association and epistasis analysis

  2015cites this paper
• SODIUM NITROPRUSSIDE AS A FAST-ACTING ANTIPSYCHOTIC AGENT

  2015cites this paper
• TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression

  2015cites this paper
• A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations

  2015cites this paper
• Direct inhibition of retinoic acid catabolism by fluoxetine

  2015cites this paper
• Anhedonia in Major Depressive Disorder: Exploration of a Predictive Clinical Phenotype

  2015cites this paper
• Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report

  2014cites this paper
• ENVOLVIMENTO DE MECANISMOS DOPAMINÉRGICOS NA ATIVIDADE ANTIDEPRESSIVA DA LEPTINA NO COMPORTAMENTO TIPO-DEPRESSÃO INDUZIDO POR LPS EM CAMUNDONGOS

  2014cites this paper
• Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report

  2014cites this paper
• Neurobiology of Kleptomania: an overview

  2014cites this paper
• Attenuation of Anxiety/Depression-like Behaviors and Neuroanatomical Changes Following Quercetin and Rutin Exposure in Zebrafish (Danio rerio)

  2014cites this paper
• Mechanisms underlying changes in anxiety/depression-related behaviors and neural circuits in zebrafish ( Danio rerio ) following exposure to Hypericum perforatum extracts

  2014cites this paper
• Pharmacogenetics of Antidepressant Drugs

  2014cites this paper
• Progress in understanding mood disorders: optogenetic dissection of neural circuits

  2014cites this paper
• Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm

  2014cites this paper
• Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis.

  2014cites this paper
• Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?

  2013cites this paper
• Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research

  2013cites this paper
• Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

  2013cites this paper
• Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system.

  2013cites this paper
• Mesolimbic dopamine D2 receptor plasticity contributes to stress resilience in rats subjected to chronic mild stress

  2013cites this paper
• Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.

  2013cites this paper
• A SYNTHETIC APPROACH TOWARDS NOVEL SERIES OF 3-(3-(1-PIPERAZINYL)PROPYL -1H-INDOLE DERIVATIVES AS MONOAMINERGIC MULTI-TARGET AGENTS. DOCKING STUDIES AND PHARMACOLOGICAL EVALUATION AT SERT, D2, AND MAO-A RECEPTORS.

  2013cites this paper
• Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

  2013cites this paper
• Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature?

  2013cites this paper
• The response to sulpiride in social anxiety disorder: D2 receptor function

  2013influential citation
• A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

  2013cites this paper
• Antidepressant‐like effect of bis‐eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system

  2013cites this paper
• Sexually dimorphic recruitment of dopamine neurons into the stress response circuitry.

  2013cites this paper
• The neurobiology of depression and antidepressant action.

  2013cites this paper
• Effect of Olanzapine on Pituitary –Gonad Axis and Spermatogenesis in Adult Male Rats

  2013cites this paper
• Funding: LM received interdisciplinary funding from the Medical Research Council and Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

  2012cites this paper
• Better Than I Thought: Positive Evaluation Bias in Hypomania

  2012cites this paper